Abstract
We describe the process research and development of a practical synthesis of glucokinase activator 1 as a potential drug for treating type 2 diabetes mellitus. The key structure, a 3,4-cis-difluori...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have